Two-Center Evaluation of Disinfectant Efficacy against Ebola Virus in Clinical and Laboratory Matrices

Ebola virus (EBOV) in body fluids poses risk for virus transmission. However, there are limited experimental data for such matrices on the disinfectant efficacy against EBOV. We evaluated the effectiveness of disinfectants against EBOV in blood on surfaces. Only 5% peracetic acid consistently reduce...

Full description

Saved in:
Bibliographic Details
Published inEmerging infectious diseases Vol. 24; no. 1; pp. 135 - 139
Main Authors Smither, Sophie J, Eastaugh, Lin, Filone, Claire Marie, Freeburger, Denise, Herzog, Artemas, Lever, M Stephen, Miller, David M, Mitzel, Dana, Noah, James W, Reddick-Elick, Mary S, Reese, Amy, Schuit, Michael, Wlazlowski, Carly B, Hevey, Michael, Wahl-Jensen, Victoria
Format Journal Article
LanguageEnglish
Published United States U.S. National Center for Infectious Diseases 01.01.2018
Centers for Disease Control and Prevention
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ebola virus (EBOV) in body fluids poses risk for virus transmission. However, there are limited experimental data for such matrices on the disinfectant efficacy against EBOV. We evaluated the effectiveness of disinfectants against EBOV in blood on surfaces. Only 5% peracetic acid consistently reduced EBOV titers in dried blood to the assay limit of quantification.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1080-6040
1080-6059
DOI:10.3201/eid2401.170504